Compare Diamondback Energy Inc (FANG) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diamondback Energy Inc vs Repligen Corporation Common Stock — how do they compare? Diamondback Energy Inc trades at $197.66 (market cap $55.49B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Diamondback Energy Inc is far larger — about 5× Repligen Corporation Common Stock's market cap, and Diamondback Energy Inc pays a 2.22% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Diamondback Energy Inc for 70 Days and Repligen Corporation Common Stock for 0 Days on average.
| FANG | RGEN | |
|---|---|---|
Market Cap | $55.49B | $11.14B |
Volume | 2,752,760 | 1,259,263 |
Sector | Energy | Health |
52-Week High | $213.69 | $194.57 |
52-Week Low | $137.29 | $102.87 |
Typical Hold Time | 70 Days | 0 Days |
Enterprise Value | $67.65B | $11.02B |
Dividend Yield | 2.22% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Diamondback Energy (FANG) trades at $198.18, up 1.57% with strong technical momentum and bullish analyst sentiment. The stock shows robust earnings performance with recent quarterly beats and solid revenue growth from $14.93B in 2025 to projected $17.0B in 2026. Technical indicators show bullish moving averages while RSI levels suggest potential overbought conditions. The company maintains strong cash flow generation with $8.76B from operations in 2025 and recently announced a $1.10 dividend payment.
FANG presents a compelling growth opportunity with 90% analyst buy ratings and a $233.79 consensus price target offering 18% upside. However, declining profit margins from 45.84% in 2022 to 11.14% in 2025 and elevated P/E ratio of 37.75 warrant caution. Oil price volatility and insider selling activity represent key risks for investors considering entry at current levels near recent highs.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diamondback Energy Inc
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2021, the company reported net proven reserves of 1.8 billion barrels of oil equivalent. Net production averaged about 375,000 barrels per day in 2021, at a ratio of 60% oil, 20% natural gas liquids, and 20% natural gas.
Read more on FANG →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
